Moving forward: continuous online publishing

From past to future in cardiovascular care and research in Ticino

In this article based on the Grüntzig Lecture 2018 the author gives his personal memories and a review of the development of cardiology in the canton of Ticino.

Die Kardiologen und die Zukunft ihres Fachs

Soluble ST2 – a new biomarker in heart failure

This article summarises insights and discussion points from the first meeting of the Swiss working group on cardiovascular bio­markers.

Optimising the early rule-out and rule-in of myocardial infarction using biomarkers

High-sensitivity cardiac troponin and other emerging cardiac biomarkers might have the potential to further improve the early triage of patients with suspected myocardial infarction.

Intensive LDL-cholesterol lowering and inhibition of inflammation to further reduce cardiovascular risk?

Over recent decades, research into the causes and mechanisms driving the development of cardiovascular disease has rapidly evolved. In everyday real life, this translates into ever more targeted treatment strategies that can be adapted to each individual’s cardiovascular history and risk.  

Chagas heart disease

Chagas heart disease is becoming a worldwide health burden and represents a major cause of cardiovascular death in areas where it is endemic.

Verschwinden Ischämie-verdächtiger EKG-Veränderungen nach Einlage eines biliären Stents

T-Negativierungen in den inferioren Ableitungen normalisierten sich nach biliärer Dekompression.

Unusual case of large vessel ­vasculitis limited to the vertebral arteries

18F-FDG PET/CTA is a useful imaging method in the ­initial diagnosis of LVV.

The first clinically used coronary stent was initiated and developed in Lausanne